News #Cancer

Biotech startup Zumutor Biologics has raised $7.3 million in a Pre-Series B funding round from existing investors Accel and Bharat Innovation Fund, along with participation from new investors

Triomics, a startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks